Almanac 2013: acute coronary syndromes

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology

Background:

• Unstable coronary artery plaque is the primary cause of acute coronary syndromes (ACS).
• ACS encompasses conditions like unstable angina, non-ST segment elevation myocardial infarction (NSTE-ACS), and ST-elevation myocardial infarction (STEMI).
• Ischemia-induced tachyarrhythmias can lead to sudden cardiac arrest.

Purpose of the Study:

• To highlight the underlying causes of acute coronary syndromes.
• To discuss the declining mortality rates associated with ACS.
• To review recent therapeutic advancements in managing ACS.

Main Methods:

• Literature review of recent therapeutic progress in ACS management.
• Analysis of trends in ACS mortality rates.
• Focus on novel antiplatelet agents.

Main Results:

• Significant decrease in ACS mortality, particularly for STEMI and cardiac arrest.
• Emergence of novel antiplatelet agents like prasugrel, ticagrelor, and cangrelor.
• Positive outlook for continued mortality reduction.

Conclusions:

• Unstable plaque remains a critical issue in cardiovascular disease.
• Therapeutic advancements, especially new antiplatelet drugs, are improving ACS outcomes.
• Future trends indicate a continued decline in ACS-related mortality.